| Date | State | Bill No. | Title | Outcome |
|---|---|---|---|---|
| June 11, 2025 | Louisiana | HB 358 | Prohibits Pharmacy Benefits Managers (PBMs) from Owning and Operating Pharmacies in the State | Conference Report Adopted - House (88 - 4) |
| June 9, 2025 | Louisiana | SB 19 | Authorizes Over-the-Counter Sale of Ivermectin | Concurrence Vote Passed - Senate (31 - 4) |
| June 3, 2025 | Louisiana | SB 19 | Authorizes Over-the-Counter Sale of Ivermectin | Bill Passed - House (67 - 26) |
| May 27, 2025 | Louisiana | SB 154 | Prohibits and Criminalizes Possession or Distribution of Kratom | Bill Passed - House (89 - 5) |
| May 6, 2025 | Louisiana | SB 154 | Prohibits and Criminalizes Possession or Distribution of Kratom | Bill Passed - Senate (26 - 11) |
| Date | No. | Title | Outcome |
|---|---|---|---|
| 6/11 | HB 358 | Prohibits Pharmacy Benefits Managers (PBMs) from Owning and Operating Pharmacies in the State | Conference Report Adopted - House (88 - 4) |
| 6/09 | SB 19 | Authorizes Over-the-Counter Sale of Ivermectin | Concurrence Vote Passed - Senate (31 - 4) |
| 6/03 | SB 19 | Authorizes Over-the-Counter Sale of Ivermectin | Bill Passed - House (67 - 26) |
| 5/27 | SB 154 | Prohibits and Criminalizes Possession or Distribution of Kratom | Bill Passed - House (89 - 5) |
| 5/06 | SB 154 | Prohibits and Criminalizes Possession or Distribution of Kratom | Bill Passed - Senate (26 - 11) |
| Date | Title | Politician |
|---|---|---|
| Aug. 15, 2024 | House GOP Leadership Statement on the Biden-Harris Administration’s Prescription Drug Price Fixing Scheme | Rep. Steve Scalise |
| July 20, 2023 | Ranking Member Cassidy Introduces SUPPORT Reauthorization Act to Continue Effort to Address the Nation's Opioid and Mental Health Crisis | Sen. Bill Cassidy |
| May 23, 2023 | Scalise: House Republicans Will Halt the Flow of Fentanyl | Rep. Steve Scalise |
| May 23, 2023 | Leader Scalise on the Biden-Manufactured Fentanyl and Debt Crises | Rep. Steve Scalise |
| Dec. 14, 2022 | Letter to Anne Milgram, Administrator of the Drug Enforcement Administration - Kennedy, Durbin urge DEA to continue reigning in excessive opioid production | Sen. John Kennedy |
| Date | Title | Politician |
|---|---|---|
| Aug. 15, 2024 | House GOP Leadership Statement on the Biden-Harris Administration’s Prescription Drug Price Fixing Scheme | Rep. Steve Scalise |
| July 20, 2023 | Ranking Member Cassidy Introduces SUPPORT Reauthorization Act to Continue Effort to Address the Nation's Opioid and Mental Health Crisis | Sen. Bill Cassidy |
| May 23, 2023 | Scalise: House Republicans Will Halt the Flow of Fentanyl | Rep. Steve Scalise |
| May 23, 2023 | Leader Scalise on the Biden-Manufactured Fentanyl and Debt Crises | Rep. Steve Scalise |
| Dec. 14, 2022 | Letter to Anne Milgram, Administrator of the Drug Enforcement Administration - Kennedy, Durbin urge DEA to continue reigning in excessive opioid production | Sen. John Kennedy |
| Year(s) | Special Interest Group |
|---|---|
| 2021 | Louisiana Association of Business and Industry (LABI) |
| Election Date | State | Title | Outcome |
|---|